HealthpointCapital Buys ImmersiveTouch XR Platform
HealthpointCapital has taken a majority position in ImmersiveTouch, Inc., broadening the private equity firm’s exposure to advanced surgical technology within the musculoskeletal sector. The transaction places ImmersiveTouch’s patented ImmersiveView™ extended-reality system under the umbrella of a fund that specialises exclusively in orthopaedic and related medical devices. Financial terms remain confidential; yet the acquisition is expected to accelerate the commercial rollout of ImmersiveTouch’s software while strengthening HealthpointCapital’s portfolio of high-growth, innovation-led businesses.
ImmersiveView™ combines virtual-reality and augmented-reality capabilities to support surgical planning, navigation and patient-specific guide production. The cloud-based platform converts conventional CT or MRI DICOM images into interactive three-dimensional models. Surgeons wearing a VR headset can manipulate anatomical structures in real-time, reconstruct fractures virtually and generate design files for bespoke implants. According to the company, the complete workflow, from image import to printable model and exportable guide, can be completed within 12 to 48 hours, significantly reducing the lead time associated with complex cranio-maxillofacial and thoracic procedures.
Inside the operating theatre, the same surgical plan may be superimposed on the patient’s body via AR glasses, enabling what ImmersiveTouch describes as an “X-ray vision” overlay of bones, vessels and nerves. By aligning the digital twin with the patient’s actual anatomy, surgeons are able to orient instruments more precisely and shorten operative times. Early adopters have reported improved theatre efficiency, fewer intra-operative adjustments and stronger opportunities for interdisciplinary collaboration, particularly among cranio-maxillofacial, ENT, plastic, neuro and general trauma teams.
Founded in Chicago by biomedical engineer Dr Pat Banerjee, ImmersiveTouch has already secured United States Food and Drug Administration 510(k) clearance for its core planning software. More than 3,000 cases have been completed with the aid of ImmersiveView™ at over 100 hospitals and academic medical centres worldwide. Company engineers continue to expand the feature set, exploring additional indications across orthopaedics, neurosurgery and cardiovascular reconstruction.
HealthpointCapital’s investment team, led by Managing Partner Mike Mogul, together with Gary Stevenson, Milen Todorov, Bill Johnson, and Lisa Holt, brings substantial operating experience to the new partnership. Over the past two decades, the firm has backed and exited several high-profile orthopaedic companies, including CrossRoads Extremity Systems (acquired by Johnson & Johnson DePuy Synthes), OrthoSpace (sold to Stryker), Blue Belt Technologies (sold to Smith+Nephew) and BioHorizons (sold to Henry Schein). The ImmersiveTouch acquisition is expected to complement those prior successes by adding an enabling software platform that integrates closely with the implant and instrumentation ecosystem.
Legal counsel for HealthpointCapital was provided by Schulte Roth & Zabel LLP and Greenberg Traurig LLP. ImmersiveTouch received advisory support from undisclosed firms. While specific valuation metrics were not released, industry analysts note that musculoskeletal diagnostics and surgical navigation technologies have commanded premium multiples in recent transactions due to their potential to reduce theatre costs and improve patient outcomes.
With surgical backlogs persisting and healthcare providers seeking efficiencies, demand for extended-reality tools continues to climb. ImmersiveTouch’s capacity to deliver rapid, patient-tailored guides aligns with the push toward value-based care and personalised medicine. HealthpointCapital intends to leverage its clinical network, distribution channels and operational expertise to scale the platform, broaden global adoption and pursue additional regulatory clearances where necessary.
Looking ahead, the new owners will focus on expanding ImmersiveView’s indication list, deepening integration with hospital information systems and exploring partnerships with implant manufacturers. In parallel, advances in headset hardware and cloud computing are expected to improve image fidelity and reduce the total cost of ownership for clinical users.
By merging HealthpointCapital’s strategic resources with ImmersiveTouch’s proprietary technology, the acquisition aims to advance extended-reality surgery from the early-adopter phase to a mainstream standard across trauma and reconstructive disciplines.
